Boothbay Fund Management’s NextCure NXTC Stock Holding History

Boothbay Fund Management’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$744K	Hold	69,617	–	–	0.01%	1118
2025 Q4	$988K	Buy	+69,617	New	+$721K	0.01%	808
2022 Q2	–	Sell	-1,123	Closed	-$65K	–	2547
2022 Q1	$65K	Hold	1,123	–	–	﹤0.01%	2152
2021 Q4	$81K	Sell	1,123 -3,140	-74%	-$263K	﹤0.01%	1736
2021 Q3	$345K	Sell	4,263 -1,050	-20%	-$92.1K	0.01%	1261
2021 Q2	$512K	Buy	5,313 +1,006	+23%	+$103K	0.02%	990
2021 Q1	$517K	Buy	4,307 +2,391	+125%	+$346K	0.02%	931
2020 Q4	$251K	Hold	1,916	–	–	0.01%	1017
2020 Q3	$202K	Buy	+1,916	New	+$236K	0.01%	944

Other funds holding NXTC

SCM

Squadron Capital Management Westmont, Illinois $273M AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

EAM

Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

Boothbay Fund Management's NXTC Position: Q1 2026 in Review

Boothbay Fund Management held its NextCure (NXTC) position steady in Q1 2026 at 69,617 shares worth $744K. The position accounts for 0.01% of the portfolio, ranked #1118.

Boothbay Fund Management first reported a position in NXTC in Q3 2020 and has held it in 9 quarters since. The position peaked at $988K in Q4 2025. 26 funds tracked by Wall St. Rank hold NXTC as of Q1 2026.

Boothbay Fund Management held 69,617 shares of NextCure worth $744K as of Q1 2026.
Boothbay Fund Management left its NextCure share count unchanged in Q1 2026.
NextCure made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1118 holding.
Boothbay Fund Management first reported a position in NextCure in Q3 2020 and has held it in 9 quarters since.
Boothbay Fund Management's NextCure position peaked at $988K in Q4 2025.
26 funds tracked by Wall St. Rank held NextCure as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.